Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 3
1993 1
1994 2
1995 4
1996 1
1997 1
1998 1
1999 1
2000 1
2001 3
2002 2
2003 5
2004 3
2005 6
2006 3
2007 3
2008 1
2009 3
2010 3
2011 3
2012 3
2013 5
2014 1
2015 4
2016 3
2017 1
2018 5
2019 6
2020 8
2021 4
2022 4
2023 6
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A.
Reckamp KL, Redman MW, Dragnev KH, Minichiello K, Villaruz LC, Faller B, Al Baghdadi T, Hines S, Everhart L, Highleyman L, Papadimitrakopoulou V, Neal JW, Waqar SN, Patel JD, Gray JE, Gandara DR, Kelly K, Herbst RS. Reckamp KL, et al. Among authors: dragnev kh. J Clin Oncol. 2022 Jul 20;40(21):2295-2306. doi: 10.1200/JCO.22.00912. Epub 2022 Jun 3. J Clin Oncol. 2022. PMID: 35658002 Free PMC article. Clinical Trial.
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial.
Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Domine Gomez M, Lowczak A, Aljumaily R, Rocha Lima CM, Boccia RV, Hanna W, Nikolinakos P, Chiu VK, Owonikoko TK, Schuster SR, Hussein MA, Richards DA, Sawrycki P, Bulat I, Hamm JT, Hart LL, Adler S, Antal JM, Lai AY, Sorrentino JA, Yang Z, Malik RK, Morris SR, Roberts PJ, Dragnev KH; G1T28-02 Study Group. Weiss JM, et al. Among authors: dragnev kh. Ann Oncol. 2019 Oct 1;30(10):1613-1621. doi: 10.1093/annonc/mdz278. Ann Oncol. 2019. PMID: 31504118 Free PMC article. Clinical Trial.
Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial.
Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA. Bakitas MA, et al. Among authors: dragnev kh. J Clin Oncol. 2015 May 1;33(13):1438-45. doi: 10.1200/JCO.2014.58.6362. Epub 2015 Mar 23. J Clin Oncol. 2015. PMID: 25800768 Free PMC article. Clinical Trial.
Pragmaticism in Cancer Clinical Trials.
Sankar K, Redman MW, Dragnev KH, Henick BS, Iams WT, Blanke CD, Herbst RS, Gray JE, Reckamp KL. Sankar K, et al. Among authors: dragnev kh. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e100040. doi: 10.1200/EDBK_100040. Am Soc Clin Oncol Educ Book. 2024. PMID: 38771997 Free article. Review.
In search of the magic bullet.
Dragnev KH. Dragnev KH. Transl Res. 2009 Jun;153(6):261-2. doi: 10.1016/j.trsl.2009.03.002. Epub 2009 Mar 27. Transl Res. 2009. PMID: 19446278 No abstract available.
The retinoic acid paradox in cancer chemoprevention.
Freemantle SJ, Dragnev KH, Dmitrovsky E. Freemantle SJ, et al. Among authors: dragnev kh. J Natl Cancer Inst. 2006 Apr 5;98(7):426-7. doi: 10.1093/jnci/djj116. J Natl Cancer Inst. 2006. PMID: 16595769 No abstract available.
Uncovering novel targets for cancer chemoprevention.
Dragnev KH, Feng Q, Ma Y, Shah SJ, Black C, Memoli V, Nugent W, Rigas JR, Kitareewan S, Freemantle S, Dmitrovsky E. Dragnev KH, et al. Recent Results Cancer Res. 2007;174:235-43. doi: 10.1007/978-3-540-37696-5_21. Recent Results Cancer Res. 2007. PMID: 17302201 Review.
104 results